文献速递免疫规划卫生政策与健康促进

加纳轮状病毒疫苗接种的成本效果:分析2012至2031年的影响

Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031.
PubMed 文献 · Vaccine · 2017-12-06

本研究使用TRIVAC模型估算加纳2012至2031年轮状病毒疫苗接种的成本与效果。结论认为即使加纳承担全部疫苗采购费用,持续接种仍极具成本效果。

要点

  • 每避免一个DALY的社会成本为238至332美元,每避免一例病例的成本为27至38美元。
  • 即使加纳承担全部疫苗采购费用,持续接种仍极具成本效果。

核心结论

  • 分析表明持续轮状病毒疫苗接种将极具成本效果,即使是在加纳从Gavi支持过渡后承担疫苗采购费用的时期也是如此。

研究设计与样本

  • 使用TRIVAC模型估算2012年至2031年轮状病毒疫苗接种的成本和效果,模型输入来自当地数据、国际文献和专家咨询,成本从卫生系统和社会视角考察。

主要发现

  • 每避免一个DALY的社会成本为238至332美元,每避免一例病例的成本为27至38美元。
  • 每避免一例死亡的成本约为7000美元。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diarrhea causes about 10% of all deaths in children under five years globally, with rotavirus causing about 40% of all diarrhea deaths. Ghana introduced rotavirus vaccination as part of routine immunization in 2012 and it has been shown to be effective in reducing disease burden in children under five years. Ghana's transition from low to lower-middle income status in 2010 implies fewer resources from Gavi as well as other major global financing mechanisms. Ghana will soon bear the full cost of vaccines. The aim of this study was to estimate the health impact, costs and cost-effectiveness of rotavirus vaccination in Ghana from introduction and beyond the Gavi transition. METHODS: The TRIVAC model is used to estimate costs and effects of rotavirus vaccination from 2012 through 2031. Model inputs include demographics, disease burden, health system structure, health care utilization and costs as well as vaccine cost, coverage, and efficacy. Model inputs came from local data, the international literature and expert consultation. Costs were examined from the health system and societal perspectives. RESULTS: The results show that continued rotavirus vaccination could avert more than 2.2 million cases and 8900 deaths while saving US$6 to US$9 million in costs over a 20-year period. The net cost of vaccination program is approximately US$60 million over the same period. The societal cost per DALY averted is US$238 to US$332 with cost per case averted ranging from US$27 to US$38. The cost per death averted is approximately US$7000. CONCLUSION: The analysis shows that continued rotavirus vaccination will be highly cost-effective, even for the period during which Ghana will assume responsibility for purchasing vaccines after transition from Gavi support.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Nonvignon J, Atherly D, Pecenka C, et al. Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031. Vaccine. 2017. PMID: 29223486. doi:10.1016/j.vaccine.2017.11.080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。